NSCLC STAGE IV
Clinical trials for NSCLC STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE IV trials appear
Sign up with your email to follow new studies for NSCLC STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Zapping growing tumors early may buy more time for metastatic cancer patients
Disease control OngoingThis study looks at whether giving precise radiation (SBRT) to tumors that have just started to grow can help people with metastatic triple-negative breast cancer or non-small cell lung cancer live longer without their disease getting worse. About 107 adults are taking part. The …
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
New hope for elderly lung cancer patients: targeted pill shows promise
Disease control OngoingThis study tests a daily pill called adagrasib in 68 patients with a specific type of advanced lung cancer (KRAS G12C mutation) who are either 70 or older or have poor physical health. The goal is to see if the drug can shrink tumors or stop them from growing. Patients take the m…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Blood test may help track lung cancer drug effectiveness
Disease control OngoingThis study looks at whether a blood test (liquid biopsy) can help doctors see how well the drug brigatinib is working in people with a specific type of advanced lung cancer (ALK-positive NSCLC). About 33 patients will take brigatinib pills and give blood samples over time. The go…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 18, 2026 12:14 UTC
-
Blood test could personalize lung cancer care, avoid unnecessary chemo
Disease control OngoingThis study tests whether a blood test taken during treatment can show if immunotherapy (pembrolizumab) is working well enough alone, or if adding chemotherapy is needed. About 40 people with stage IV non-small cell lung cancer will give blood samples at different times. The goal …
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Julia K. Rotow, MD • Aim: Disease control
Last updated May 18, 2026 12:02 UTC